Apogee Therapeutics, Inc. (APGE)
APGE · Biological Products, (No Diagnostic Substances) · Waltham, MA · filing with the SEC since 2023
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
| Report filed | Mar 2, 2026 | Mar 3, 2025 | Mar 5, 2024 | · |
| Research and development | 214,712 | 167,865 | 68,424 | · |
| General and administrative | 70,883 | 49,005 | 24,579 | · |
| Total operating expenses | 285,595 | 216,870 | 93,003 | · |
| Operating income | -285,595 | -216,870 | -93,003 | · |
| Interest and investment income | 30,030 | 34,742 | 9,018 | · |
| Other income (expense), net | 30,030 | 34,742 | 9,018 | · |
| Income before income taxes | -255,565 | -182,128 | -83,985 | · |
| Income tax expense | 278 | 18 | 0 | · |
| Net income including non-controlling interests | -255,843 | -182,146 | -83,985 | · |
| Net income | -255,843 | -182,146 | -83,985 | · |
| Net income to common shareholders | -255,843 | -182,146 | -83,985 | · |
| Earnings per share, basic | -4.22 | -3.30 | -3.36 | · |
| Earnings per share, diluted | -4.22 | -3.30 | -3.36 | · |
| Weighted average shares, basic | 60,690,820 | 55,193,971 | 25,005,774 | · |
| Weighted average shares, diluted | 60,690,820 | 55,193,971 | 25,005,774 | · |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossNet income to common shareholders what is left for common shareholders
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasicEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding